BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21684836)

  • 1. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
    Béchade D
    Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
    Béchade D
    Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
    Canto MI
    Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
    Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
    Wiesenauer CA; Schmidt CM; Cummings OW; Yiannoutsos CT; Howard TJ; Wiebke EA; Goulet RJ; McHenry L; Sherman S; Lehman GA; Cramer H; Madura JA
    Arch Surg; 2003 Jun; 138(6):610-7; discussion 617-8. PubMed ID: 12799331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
    Katabi N; Klimstra DS
    J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer screening: identifying premalignant disease.
    James TA; Gibbs JF
    Future Oncol; 2005 Apr; 1(2):191-5. PubMed ID: 16555989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas.
    Sahani DV; Lin DJ; Venkatesan AM; Sainani N; Mino-Kenudson M; Brugge WR; Fernandez-Del-Castillo C
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):259-69. PubMed ID: 19121413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small undifferentiated pancreatic adenocarcinoma which mimics IPMN at imaging.
    D'Onofrio M; Vecchiato F; Gallotti A; Falconi M; Capelli P; Pozzi Mucelli R
    JOP; 2009 Jul; 10(4):406-8. PubMed ID: 19581744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of gene expression profiling of pancreatic cancer.
    Goonetilleke KS; Siriwardena AK
    Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can an intraductal papillary mucinous tumor be a potential indicator of concurrent adenocarcinoma of the pancreas?
    Jarry J; Belleannee G; Rault A; Sa Cunha A; Collet D
    JOP; 2010 Jan; 11(1):55-7. PubMed ID: 20065554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Harada R; Kawamoto H; Fukatsu H; Kato H; Hirao K; Kurihara N; Mizuno O; Ogawa T; Ishida E; Okada H; Yamamoto K; Yamamoto H
    Pancreas; 2010 Apr; 39(3):340-4. PubMed ID: 19823100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.
    Ringel J; Löhr M
    Mol Cancer; 2003 Jan; 2():9. PubMed ID: 12556240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imaging of intraductal papillary mucinous tumor of the pancreas: literature review].
    Valette O; Cuilleron M; Debelle L; Antunes L; Mosnier JF; Régent D; Veyret C
    J Radiol; 2001 Jun; 82(6 Pt 1):633-45. PubMed ID: 11449165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.